223259-63-0

Basic information

• Product Name: 1,1'-SPIROBIINDANE-7,7'-DIOL
• Synonyms: 1,1'-SPIROBIINDANE-7,7'-DIOL;(1S)-2,2',3,3'-tetrahydro-1,1'-Spirobi[1H-indene]-7,7'-diol;(S)-2,2',3,3'-TETRAHYDRO-1,1'-SPIROBI[INDENE]-7,7'-DIOL, >=95%;S-2,2',3,3'-Tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol;S-2,2',3,3'-tetrahydro-1,1'-spirobi[indene]-7,7'-diol; 1,1'-Spirobi[1H-indene]-7,7'-diol,2,2',3,3'-tetrahydro-;1,1'-Spirobi[1H-indene]-7,7'-diol, 2,2',3,3'-tetrahydro-, (1S)-;(S)-2,2',3,3'-Tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol, 99%e.e.
• CAS NO: 223259-63-0
• Molecular Formula: C₁₇H₁₆O₂
• Molecular Weight: 252.30774
• Product Categories: BINOL Series;Chiral Oxygen;Chiral Spiro Ligand
• Mol File: 223259-63-0.mol
• Article Data: 7

Chemical Properties

• Melting Point: 155-156℃
• Boiling Point: 433.0±45.0 °C(Predicted)
• Appearance: /
• Density: 1.34±0.1 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 9.70±0.20(Predicted)
• CAS DataBase Reference: 1,1'-SPIROBIINDANE-7,7'-DIOL(CAS DataBase Reference)
• NIST Chemistry Reference: 1,1'-SPIROBIINDANE-7,7'-DIOL(223259-63-0)
• EPA Substance Registry System: 1,1'-SPIROBIINDANE-7,7'-DIOL(223259-63-0)

Safety Data

• Hazardous Substances Data: 223259-63-0(Hazardous Substances Data)

Usage

Uses

(S)-SPINOL is used to synthesis a new class of chiral phosphoric acids with spirobiindane as scaffold and employed to catalyze the asymmetric Friedel?Crafts reaction of indoles with imines to afford 3-indolyl methanamines.

Upstream product

• 100-83-4 meta-hydroxybenzaldehyde 
• 636601-27-9 (S)-4,4'-dibromo-2,2',3,3'-tetrahydro-1,1'-spirobi[indene]-7,7'-diol 
• 1427054-10-1 1,5-bis(2-bromo-5-hydroxyphenyl)pentan-3-one 
• 1427054-08-7 1,5-bis(3-hydroxyphenyl)pentan-3-one 
• 881915-97-5 (1E,4E)-1,5-bis(3-hydroxyphenyl)penta-1,4-dien-3-one 
• 223137-76-6 4,4'-dibromo-7,7'-dimethoxy-1,1'-spirobiindane 
• 223137-71-1 1,5-bis-(2-bromo-5-methoxyphenyl)-3-pentanone 
• 223137-81-3 7,7'-dimethoxy-1,1'-spirobiindane 
• 458533-66-9 (1E,4E)-1,5-bis(3-methoxyphenyl)penta-1,4-dien-3-one 
• 591-31-1 3-methoxy-benzaldehyde 
• 223137-67-5 1,5-bis(3-methoxyphenyl)-3-pentanone 
• 223137-87-9 (R)-2,2',3,3'-tetrahydro-1,1'-spirobi[indene]-7,7'-diol 
• 116836-15-8 1,5-bis(3-methoxyphenyl)-1,4-pentadien-3-one 

Downstream Products

• 223137-87-9 (R)-2,2',3,3'-tetrahydro-1,1'-spirobi[indene]-7,7'-diol 
• 223137-87-9 2,2′,3,3′-tetrahydro-1,1′-spirobi[indene]-7,7′-diol 
• 500997-67-1 [(R)-1,1'-spirobiindane-7,7'-diyl] diisopropylamidophosphite 
• 1286189-16-9 C₃₃H₂₀F₁₂O₂ 
• 1286189-15-8 6,6'-dibromo-2,2',3,3'-tetrahydro-1,1'-spirobi[indene]-7,7'-diol 

Relevant articles and documents

A ligand synthesis of butadiene adhesive

The invention relates to a synthesis method of ligand butadiene adhesive, to 3 - hydroxybenzaldehyde with acetone as the starting material, condensation to obtain the 1, 5 - double-(3 - hydroxy-phenyl) - 1, 4 - isoprene ketone, the 1, 5 - double-(3 - hydr

Chiral oligomers of spiro-salencobalt(III)X for catalytic asymmetric cycloaddition of epoxides with CO2

Several new chiral oligomers of spiro-salenCo(III)X (spiro = 1.1′-spirobiindane-7.7′-diol) complexes have been designed, synthesized, and characterized by nuclear magnetic resonance (NMR), infrared (IR), and elemental analyses, in which, the chiral spiro moieties are first introduced into a scaffold of chiral salenCo catalysts. They were used to catalyze the asymmetric cycloaddition of epoxides with carbon dioxide. Under very mild reaction conditions, a kinetic resolution of racemic epoxides with CO2 was smoothly initiated by these chiral oligomer catalysts with good enantioselectivities, which can be attributed to the match effect between chiral backbones of salen and spiro. High stability and easy recyclability are their major advantages.

CHIRAL COMPOUNDS AND COMPOSITIONS CONTAINING THE SAME

The invention relates to a novel class of compounds useful as chiral dopants, which compounds are available in both enantiomeric forms. Another aspect of the invention relates to such compounds having a enantiomeric excess of one enantiomeric form, which are useful in liquid crystal formulations. Such formulations are advantageous in displays and various other products.